tiprankstipranks
Trending News
More News >
West Pharmaceutical Services, Inc. (WST)
NYSE:WST
US Market
Advertisement

West Pharmaceutical Services (WST) Stock Forecast & Price Target

Compare
809 Followers
See the Price Targets and Ratings of:

WST Analyst Ratings

Strong Buy
9Ratings
Strong Buy
8 Buy
1 Hold
0 Sell
Based on 9 analysts giving stock ratings to
West
Pharmaceutical Services
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

WST Stock 12 Month Forecast

Average Price Target

$308.75
▲(23.89%Upside)
Based on 9 Wall Street analysts offering 12 month price targets for West Pharmaceutical Services in the last 3 months. The average price target is $308.75 with a high forecast of $350.00 and a low forecast of $245.00. The average price target represents a 23.89% change from the last price of $249.21.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"208":"$208","351":"$351","243.75":"$243.8","279.5":"$279.5","315.25":"$315.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":350,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$350.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":308.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$308.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":245,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$245.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[208,243.75,279.5,315.25,351],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,222.24,232.0676923076923,241.89538461538461,251.72307692307692,261.5507692307692,271.3784615384615,281.2061538461538,291.0338461538462,300.86153846153843,310.6892307692308,320.51692307692304,330.3446153846154,340.1723076923077,{"y":350,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,222.24,228.8946153846154,235.54923076923077,242.20384615384617,248.85846153846154,255.51307692307694,262.16769230769233,268.8223076923077,275.4769230769231,282.13153846153847,288.78615384615387,295.4407692307692,302.0953846153846,{"y":308.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,222.24,223.99076923076925,225.74153846153848,227.4923076923077,229.24307692307693,230.99384615384616,232.7446153846154,234.4953846153846,236.24615384615385,237.99692307692308,239.74769230769232,241.49846153846153,243.24923076923076,{"y":245,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":330.17,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":323.33,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":312.66,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":298.87,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":315.52,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.86,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.76,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":340.71,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":231.92,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":219.76,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.08,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.22,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.24,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$350.00Average Price Target$308.75Lowest Price Target$245.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on WST
TipRanks AITipRanks
Not Ranked
TipRanks
$318
Buy
27.60%
Upside
Reiterated
07/30/25
West Pharmaceutical Services' overall score is driven by robust financial performance and positive earnings guidance, despite some valuation concerns. Technical indicators and earnings call sentiment suggest strong near-term prospects, but valuation and long-term resistance warrant caution.
Jefferies Analyst forecast on WST
David WindleyJefferies
Jefferies
$245$335
Buy
34.42%
Upside
Reiterated
07/25/25
Jefferies Sticks to Their Buy Rating for West Pharmaceutical Services (WST)West Pharmaceutical (WST, BUY, PT $335) – Raise PT to $335, maintain Buy.
UBS
$285$320
Buy
28.41%
Upside
Reiterated
07/25/25
UBS Reaffirms Their Buy Rating on West Pharmaceutical Services (WST)
KeyBanc
$325
Buy
30.41%
Upside
Reiterated
07/25/25
KeyBanc Remains a Buy on West Pharmaceutical Services (WST)
Citi
$300$350
Buy
40.44%
Upside
Reiterated
07/25/25
Citi Sticks to Its Buy Rating for West Pharmaceutical Services (WST)
Evercore ISI Analyst forecast on WST
Vijay KumarEvercore ISI
Evercore ISI
$275$350
Buy
40.44%
Upside
Reiterated
07/25/25
Strong Growth Prospects and Margin Recovery Justify Buy Rating for West Pharmaceutical Services
Barclays Analyst forecast on WST
Luke SergottBarclays
Barclays
$245
Hold
-1.69%
Downside
Reiterated
07/25/25
Barclays Keeps Their Hold Rating on West Pharmaceutical Services (WST)
William Blair Analyst forecast on WST
Matt LarewWilliam Blair
William Blair
Buy
Reiterated
07/24/25
Strong Performance and Promising Outlook: West Pharmaceutical Services Receives Buy Rating from Matt LarewWest Pharmaceutical Services, Inc. (WST) - From: , Thursday, July 24, 2025 11:48 AM Research | Services, Inc.
Bank of America Securities Analyst forecast on WST
Michael RyskinBank of America Securities
Bank of America Securities
$280
Buy
12.36%
Upside
Reiterated
07/18/25
Bank of America Securities Keeps Their Buy Rating on West Pharmaceutical Services (WST)
DBS
$265
Buy
6.34%
Upside
Reiterated
06/03/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (NYSE: WST), Blueprint Medicines (NASDAQ: BPMC) and Vera Therapeutics (NASDAQ: VERA)
Deutsche Bank  Analyst forecast on WST
Justin BowersDeutsche Bank
Deutsche Bank
$250
Buy
0.32%
Upside
Upgraded
02/14/25
West Pharmaceutical upgraded to Buy from Hold at Deutsche BankWest Pharmaceutical upgraded to Buy from Hold at Deutsche Bank
Wolfe Research Analyst forecast on WST
Doug SchenkelWolfe Research
Wolfe Research
Hold
Initiated
12/13/24
West Pharmaceutical initiated with a Peer Perform at Wolfe ResearchWest Pharmaceutical initiated with a Peer Perform at Wolfe Research
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on WST
TipRanks AITipRanks
Not Ranked
TipRanks
$318
Buy
27.60%
Upside
Reiterated
07/30/25
West Pharmaceutical Services' overall score is driven by robust financial performance and positive earnings guidance, despite some valuation concerns. Technical indicators and earnings call sentiment suggest strong near-term prospects, but valuation and long-term resistance warrant caution.
Jefferies Analyst forecast on WST
David WindleyJefferies
Jefferies
$245$335
Buy
34.42%
Upside
Reiterated
07/25/25
Jefferies Sticks to Their Buy Rating for West Pharmaceutical Services (WST)West Pharmaceutical (WST, BUY, PT $335) – Raise PT to $335, maintain Buy.
UBS
$285$320
Buy
28.41%
Upside
Reiterated
07/25/25
UBS Reaffirms Their Buy Rating on West Pharmaceutical Services (WST)
KeyBanc
$325
Buy
30.41%
Upside
Reiterated
07/25/25
KeyBanc Remains a Buy on West Pharmaceutical Services (WST)
Citi
$300$350
Buy
40.44%
Upside
Reiterated
07/25/25
Citi Sticks to Its Buy Rating for West Pharmaceutical Services (WST)
Evercore ISI Analyst forecast on WST
Vijay KumarEvercore ISI
Evercore ISI
$275$350
Buy
40.44%
Upside
Reiterated
07/25/25
Strong Growth Prospects and Margin Recovery Justify Buy Rating for West Pharmaceutical Services
Barclays Analyst forecast on WST
Luke SergottBarclays
Barclays
$245
Hold
-1.69%
Downside
Reiterated
07/25/25
Barclays Keeps Their Hold Rating on West Pharmaceutical Services (WST)
William Blair Analyst forecast on WST
Matt LarewWilliam Blair
William Blair
Buy
Reiterated
07/24/25
Strong Performance and Promising Outlook: West Pharmaceutical Services Receives Buy Rating from Matt LarewWest Pharmaceutical Services, Inc. (WST) - From: , Thursday, July 24, 2025 11:48 AM Research | Services, Inc.
Bank of America Securities Analyst forecast on WST
Michael RyskinBank of America Securities
Bank of America Securities
$280
Buy
12.36%
Upside
Reiterated
07/18/25
Bank of America Securities Keeps Their Buy Rating on West Pharmaceutical Services (WST)
DBS
$265
Buy
6.34%
Upside
Reiterated
06/03/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: West Pharmaceutical Services (NYSE: WST), Blueprint Medicines (NASDAQ: BPMC) and Vera Therapeutics (NASDAQ: VERA)
Deutsche Bank  Analyst forecast on WST
Justin BowersDeutsche Bank
Deutsche Bank
$250
Buy
0.32%
Upside
Upgraded
02/14/25
West Pharmaceutical upgraded to Buy from Hold at Deutsche BankWest Pharmaceutical upgraded to Buy from Hold at Deutsche Bank
Wolfe Research Analyst forecast on WST
Doug SchenkelWolfe Research
Wolfe Research
Hold
Initiated
12/13/24
West Pharmaceutical initiated with a Peer Perform at Wolfe ResearchWest Pharmaceutical initiated with a Peer Perform at Wolfe Research
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering West Pharmaceutical Services

1 Month
xxx
Success Rate
5/7 ratings generated profit
71%
Average Return
+3.27%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 71.43% of your transactions generating a profit, with an average return of +3.27% per trade.
3 Months
xxx
Success Rate
8/13 ratings generated profit
62%
Average Return
+6.17%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 61.54% of your transactions generating a profit, with an average return of +6.17% per trade.
1 Year
Success Rate
9/13 ratings generated profit
69%
Average Return
+12.55%
reiterated a buy rating 7 days ago
Copying Paul Knight's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +12.55% per trade.
2 Years
xxx
Success Rate
8/13 ratings generated profit
62%
Average Return
+17.98%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 61.54% of your transactions generating a profit, with an average return of +17.98% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

WST Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
2
2
1
0
0
Buy
7
10
11
13
23
Hold
0
0
1
2
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
9
12
13
15
28
In the current month, WST has received 23 Buy Ratings, 5 Hold Ratings, and 0 Sell Ratings. WST average Analyst price target in the past 3 months is 308.75.
Each month's total comprises the sum of three months' worth of ratings.

WST Financial Forecast

WST Earnings Forecast

Next quarter’s earnings estimate for WST is $1.68 with a range of $1.65 to $1.72. The previous quarter’s EPS was $1.84. WST beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 78.57% of the time in the same period. In the last calendar year WST has Outperformed its overall industry.
Next quarter’s earnings estimate for WST is $1.68 with a range of $1.65 to $1.72. The previous quarter’s EPS was $1.84. WST beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 78.57% of the time in the same period. In the last calendar year WST has Outperformed its overall industry.

WST Sales Forecast

Next quarter’s sales forecast for WST is $786.13M with a range of $762.10M to $791.90M. The previous quarter’s sales results were $766.20M. WST beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 81.82% of the time in the same period. In the last calendar year WST has Outperformed its overall industry.
Next quarter’s sales forecast for WST is $786.13M with a range of $762.10M to $791.90M. The previous quarter’s sales results were $766.20M. WST beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 81.82% of the time in the same period. In the last calendar year WST has Outperformed its overall industry.

WST Stock Forecast FAQ

What is WST’s average 12-month price target, according to analysts?
Based on analyst ratings, West Pharmaceutical Services, Inc.’s 12-month average price target is 308.75.
    What is WST’s upside potential, based on the analysts’ average price target?
    West Pharmaceutical Services, Inc. has 23.89% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is WST a Buy, Sell or Hold?
          West Pharmaceutical Services, Inc. has a consensus rating of Strong Buy which is based on 8 buy ratings, 1 hold ratings and 0 sell ratings.
            What is West Pharmaceutical Services, Inc.’s price target?
            The average price target for West Pharmaceutical Services, Inc. is 308.75. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $350.00 ,the lowest forecast is $245.00. The average price target represents 23.89% Increase from the current price of $249.21.
              What do analysts say about West Pharmaceutical Services, Inc.?
              West Pharmaceutical Services, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
                How can I buy shares of WST?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis